Headquartered within steps of the USPTO with an affiliate office in Tokyo, Oblon is one of the largest law firms in the United States focused exclusively on intellectual property law.
1968
Norman Oblon with Stanley Fisher and Marvin Spivak launched what was to become Oblon, McClelland, Maier & Neustadt, LLP, one of the nation's leading full-service intellectual property law firms.
Outside the US, we service companies based in Japan, France, Germany, Italy, Saudi Arabia, and farther corners of the world. Our culturally aware attorneys speak many languages, including Japanese, French, German, Mandarin, Korean, Russian, Arabic, Farsi, Chinese.
Oblon's professionals provide industry-leading IP legal services to many of the world's most admired innovators and brands.
From the minute you walk through our doors, you'll become a valuable part of a team that fosters a culture of innovation, client service and collegiality.
The United States Patent and Trademark Office (USPTO) issued final rules implementing the inventor's oath or declaration provisions of the America Invents Act (AIA) on August 14, 2012.
April 28-30, 2024
November 16, 2023 - In-Person in Munich
October 27, 2023
“A Woman's Perspective: How a Copyright, Patent and Trademark Can Make a Difference”
Featured Speaker: Dr. Florence Haseltine
The AIPLA Northern Virginia Women in IP networking dinner hosted by Oblon Spivak, was, according to all who attended, a great success. In addition to sharing many of her experiences in the academic and business arenas, Dr. Haseltine shared many words of wisdom and experience, including "pay attention to what you pay attention to". Following this advice ensures that we will do what interests us and succeed as a result of that interest and passion. Please see photos below from the event.
Dr. Haseltine is a biophysicist, reproductive endocrinologist, journal editor, novelist, patent holder, and advocate for women’s health. Among other things, Dr. Haseltine urged NIH and Congress to expand heart disease and cancer research to female subjects, efforts that were instrumental in securing and increasing federal funding of breast cancer research in the 1990s. The Kilby Awards Foundation has credited Dr. Haseltine with “quietly changing the course of medical history through her dynamic influence on public policy and funding of medical research to include women in critical clinical trials, saving countless lives in the process.” Dr. Haseltine is a champion of women’s health, and to date, continues to be a visionary for professional females.